Read more

March 12, 2021
1 min read
Save

Top stories from ACTRIMS: Awareness of COVID-19, inflammation’s impact on treatment

This year, ACTRIMS held their sixth annual forum virtually. From Feb. 25-27, attendees logged on for presentations related to this year’s meeting theme, “The Spectrum of Multiple Sclerosis.”

Healio Neurology covered the meeting, highlighting the latest in MS research. One presentation described increased awareness of COVID-19 among patients with MS, as well as healthy controls and health care providers. This was the top Healio Neurology story from ACTRIMS.

Another top story focused on a lecture detailing the role inflammation plays in the disease’s progressive and treatment. Healio Neurology spoke with Benjamin Segal, MD, the chair of neurology and director of the Neuroscience Research Institute at The Ohio State University Wexner Medical Center, who delivered the lecture.

Read these and more top stories from ACTRIMS below.

Patients with MS report increased awareness of COVID-19

Patients with MS, healthy controls and health care providers demonstrated increased awareness about the risk for COVID-19 infection, according to results from a cross-sectional survey presented at the ACTRIMS virtual meeting. Read more.

VIDEO: Lecture highlights role of inflammation in MS disease course, treatment

In this video perspective, Benjamin Segal, MD, discussed the Kenneth P. Johnson Memorial Lecture he delivered at the ACTRIMS virtual meeting. Read more.

Sun exposure reduces risk for pediatric-onset MS

Spending more time in sunlight was associated with a significantly reduced risk for pediatric-onset MS, according to findings presented at the ACTRIMS virtual meeting. Read more.

VIDEO: ACTRIMS Forum focuses on spectrum of MS

In this video perspective, Anne Cross, MD, an MS specialist at Washington University in St. Louis and program director of ACRTIMS Forum 2021, discussed the theme of this year’s conference: “The spectrum of multiple sclerosis.” Read more.

Novel tool links concealment of MS with depression, anxiety

A survey instrument developed to assess disclosure vs. concealment of MS diagnosis identified an association with depression and anxiety, according to research presented at the ACTRIMS virtual meeting. Read more.